Oscar Health (NYSE:OSCR) Stock Price Down 4.5% – Here’s Why

Oscar Health, Inc. (NYSE:OSCR)’s share price traded down 4.5% on Monday . The company traded as low as $13.16 and last traded at $13.46. 733,851 shares were traded during mid-day trading, a decline of 79% from the average session volume of 3,486,025 shares. The stock had previously closed at $14.09.

Analyst Upgrades and Downgrades

Several research firms have weighed in on OSCR. Piper Sandler reiterated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Finally, UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $21.56.

Oscar Health Trading Down 3.8 %

The firm has a market cap of $3.35 billion, a PE ratio of -225.96 and a beta of 1.63. The firm has a fifty day simple moving average of $15.89 and a two-hundred day simple moving average of $17.39. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter last year, the company posted ($0.29) EPS. Equities analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insider Transactions at Oscar Health

In other news, Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was bought at an average cost of $13.68 per share, with a total value of $5,756,803.92. Following the completion of the purchase, the director now directly owns 5,452,081 shares of the company’s stock, valued at $74,584,468.08. This represents a 8.36 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman Joshua Kushner purchased 358,619 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The shares were purchased at an average price of $13.74 per share, for a total transaction of $4,927,425.06. Following the completion of the acquisition, the insider now directly owns 5,810,700 shares in the company, valued at $79,839,018. The trade was a 6.58 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health during the second quarter worth $78,000. Quest Partners LLC acquired a new position in Oscar Health during the 2nd quarter valued at about $93,000. KBC Group NV raised its stake in Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after buying an additional 1,328 shares during the last quarter. Amalgamated Bank boosted its holdings in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after acquiring an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors purchased a new stake in shares of Oscar Health during the third quarter worth about $142,000. 75.70% of the stock is currently owned by institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.